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1. Introduction 
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2. Materials and methods 
Recent studies have indicated that both enzyme 
and: enzyme immunoassay may overcome some 
serious drawbacks inherent in the radioimmunoassay 
technique [1-3]. The sensitivity and precision of any 
immunoassay s stem however depends in part on the 
purity of the label used and unfortunately previous 
workers in the enzyme immunoassay field have not 
extensively purified their enzyme-conjugate labels. 
Affinity chromatography procedures for the purifica- 
tion of enzyme conjugates which enables pure conju- 
gates to be obtained are therefore described. 
The development of any sensitive nzyme immuno- 
assay or enzyme inhibition technique demands a criti- 
cal choice of high specific activity enzyme [1 ], which 
has to be stable on chemical modification, a d the 
measurement of its enzyme activity must be simple 
and sensitive. The properties ofE. coli, (/3-D-galactoside 
galactohydrolase EC 3.2.1.23) appear to satisfy most 
of these requirements, and a pure oestradiol-17/~ 
conjugate of this enzyme has been prepared. 
Purification of this conjugate must be such that it 
does not contain any unconjugated (active or denatured) 
enzyme, or any unconjugated steroid. Consideration 
of the antibody-steroid interaction i volved in enzyme 
immunoassay shows that maximum sensitivity is
achieved by a 1 : 1 enzyme/steroid ratio, and that 
maximum specificity is obtained when the homologous 
hapten (identical to that used for the assay antiserum) 
is conjugated to the enzyme. The preparation of an 
E. coli /3-D-galactosidase-oestradiol-17/3 conjugate 
which takes all the above considerations into account 
is described. 
2.1. Reagents 
[2.4.6.7-3H]Oestradiol-17/3 (spec. act. 85 Ci/mM) 
was obtained from the Radiochemical Centre, 
Amersham, England and non-radioactive steroids from 
Koch-Light, Colnbrook, Bucks, England. 1 Cyclohexyl- 
3-(2-morphinoethyl) carbodiimide metho-p-toluene 
sulphonate (CMC) and 1-ethyl-3-(3)-dimethyl-amino- 
propyl carbodiimide-HCl (EDC) were obtained from 
Sigma, St Louis, USA. Sepharose 4B and 6B, CH-Seph- 
arose 4B, DEAE-Sephadex A 50 and Sephadex G-10 
were obtained from Pharmacia, Uppsala, Sweden. 
Norit A charcoal was purchased from Sigma, St Louis, 
USA and the synthetic substrate 4-methylumbelliferyl- 
galaetoside from Koch-Light, Colnbrook, Bucks, i
England. 
The hapten used for enzyme conjugation, oestradiol- 
17/~-6-(O-carboxymethyl)-oxime (E26CMO) was 
synthesised according to Dean, Exley and Johnson 
[4]. Oestrone-6-(O-carboxymethyl) oxime (E16CMO) 
was prepared according to Dean, Rowe and Exley [5]. 
Antiserum to oestradiol-170 raised by E26CMO-BSA 
was prepared according to Exley, Johnson and Dean 
[6] and to oestrone raised by E16CMO-BSA by the 
method of Dean, Rowe and Exley [5]. Antiserum to 
oestradiol-17/3-3-glucuronide was a gift from Professor 
A. E. Kellie of the Middlesex Hospital, London, England. 
The enzyme activity of/3-D-galactosidase was measured 
using the fluorimetric technique of Robinson [7]. 
Galactosylamine was coupled to CH-Sepharose 4B 
by EDC using a modification of the method of 
Cuatrecasas nd Anfinsen [8]. The product was 
stored at 4°C until use. Phosphate-azid-saline (PAS) 
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buffer, pH 7.0, was prepared according to Abrahams 
[9]. 
2.2. Preparation of the conjugate 
Figure 1 shows the steps involved in the preparation 
and purification of the conjugate. The first step was to 
prepare the extensively purified enzyme from E. coil 
Mutant K12 3300 cells were cultured and harvested 
in the normal way and then the cells ruptured in a 
French press machine. The resultant suspension was 
centrifuged to remove insoluble material before 
subjection to 40% w/v ammonium sulphate pr cipi- 
tation. The crude enzyme was extensively purified by 
gel f'titration on Sepharose 6B (Abuknesha nd Brown 
to be published). 
The conjugate was prepared using E26CMO. 
Condensation of this compound with lysyl groups of 
the enzyme to form a peptide link was effected using 
the carbodiimide CMC. An intermediate of E26CMO 
and CMC was first formed in weak (0.01 M)acetate 
buffer, pH 4.7, by reacting 20 mg enzyme with 0.4 mg 
of E26CMO at 10-15°C for 30 min. This intermediate 
was added slowly over 10 min to a solution of the 
enzyme in (0.1 M) acetate buffer, pH 5.8. The stoichio- 
merry of the reaction was arranged togive a minimal 
steroid/enzyme ratio (usually a 20-50 m ratio of 
steroid to enzyme was required to give at)out 30% 
yidd of such conjugate). The mixture was then stirred 
at 4°C overnight and the reaction stopped by adding 
phosphate buffer, pH 7.2. 
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Fig.1. Flow chart of preparation a ~ purification of 
enzyme-steroid eonjugate~ 
2.3. Purification of the con/ugate 
As shown in fig.l, 3 steps are involved in the 
purification of the crude conjugate (C0. First, the 
majority of the unconjugated steroid, and carbodiimide 
by-products were removed by dialysis, and then last 
traces by use of a Sephadex G-10 column in series with 
a small charcoal column. After this treatment fractions 
containing the enzyme were collected and concentrated. 
This was the partially purified conjugate (C2). The 
next purification step involved affinity chromatography 
to remove non-enzymically active mol cules (whether 
conjugated to steroid or not) from C2. This conjugate 
was poured down a column of CH-Sepharose 4B-gal- 
actosylamine which was washed with PAS buffer until 
no further protein was detected in the eluate. The 
affinity bound active enzyme was then eluted with 
100 mM galactose. Fractions containing he active 
enzyme were concentrated and dialysed and provided 
the partially purified conjugate (C3). 
The last step in the purification, one that removes 
all unconjugated nzyme, is a focal one. This again 
involved affinity chromatography. Antiserum raised 
against oestrone-6-(O-carboxymethyl) oxime 
(E16CMO-BSA which is heterologous, tothe hapten 
(E26CMO) conjugated to the enzyme was coupled to 
activated Sepharose 4B. In this heterologous affinity 
chromatography technique the affinity of the bound 
antiserum for the F_~6CMO moiety of the conjugates 
was only 10% of that for its homologous hapten 
(E~6CMO), thus excess antibodies were bound to 
ensure fficient immunoadsorption. This affinity column 
attracted the enzyme-E26CMO conjugate only. After 
immunoadsorption and elution of the free enzyme by 
PAS buffer, the bound conjugate was eluted from the 
column by the stronger affinity homologous hapten 
E16CMO. The column fractions containing the conju- 
gate were then concentrated and dialysed to remove 
most of the E~6CMO eluant, then subjected to 
Sephadex G-10 and charcoal tre tment before f'mally 
concentrating with polyethylene glycol. This was the 
final purified conjugate C4. 
3. Results 
Results howed the final enzyme specific activity of 
conjugate C4 to be 90% or more of that of the original 
enzyme before conjugation (Ez2) (fig. 1) suggesting 
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that little enzymatic activity had been destroyed in
the process. The immunogenicity of the conjugate C4 
to the homologous anti Fa 6CMO-BSA serum was 
tested before and after the final affinity chromato- 
graphy purification step, by comparing the inhibition 
of binding of [2,4,6,7-3H]oestradiol-17/3 produced by 
different amounts of the conjugate with that of known 
quantities of non-radioactive o stradiol-17/3. The 
radioimmunoassay technique of Hotchkiss, Atkinson 
and Knobil [10] was used for this test, result showed 
that the immunogenicity of Ca was greatly increased 
by the last affinity chromatography step and that it 
was highly immunogenic. Methods of determining the 
number of steroids bound per enzyme molecule are 
now being developed. 
A typical enzyme immunoassay standard curve for 
the determination f oestradiol-17/3 is shown in fig.2. 
Curves were obtained using the/3-D-galactosidase- 
oestradiol-17/3 conjugate and using either the 
homologous (anti E26CMO--BSA) serum or an hetero- 
logous antiserum to oestradiol-17/3-3 glucuronide- 
BSA. The heterologous antiserum gives better 
sensitivity but this is at the expense of specificity. The 
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Fig.2. Standard curves howing % bound enzyme activity 
against pg oestradiol-17# added, obtained for enzyme- 
immunoassay using the E26CMO-#-D-galactosidase conjugate 
with ffomologous antfserum in ]~26CMO-BSA (A - A) and 
with heterologous antiserum, i.e., E2-3 glucuronide-BSA 
(o - o). Enzyme was assayed using 4-methylumbelliferyl- 
galactoside. 
method of separating bound from free conjugate was 
by the double antibody solid phase (DASP) method 
in which the second antibody (goat anti-rabbit 
q-globulin) was bound to Sepharose 4B. 
4. Discussion 
The present enzyme-conjugate purification procedure 
is more comprehensive than those previously described 
by other workers who invariably have not included 
any step to remove non-enzymicaUy ctive molecules. 
Despite the necessity of all the purification steps, once 
prepared, a gram of enzyme conjugate will provide 
enough label for millions of enzyme immunoassays. 
Present sensitivity of the enzyme immunoassay of 
oestradiol-17/3 using the purified conjugate (fig.2) 
approaches that of radioimmunoassay for this hormone. 
However the double antibody solid phase (DASP) 
system used for the assay separation stage did not 
enable the maximum potential sensitivity to be 
obtained, thus other separation steps are being studied. 
The present preparation and purification procedure 
can be used for enzyme-conjugates used in enzyme 
inhibition immunoassays. It is this technique in 
particular [2] which could in the future supersede 
radioimmunoassay, on the counts of cost, simplicity, 
speed and ease of automation. 
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